C50.9
Conditions
Interventions
Group 1: The documentation of the data history, diagnosis, pathology, therapy and follow-up is made by the physician in charge of the participating institutions. The completed case report forms are se
Sponsors
Universitätsfrauenklinik
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patient with histologically confirmed, primary breast cancer - Written consent of the patient for data collection and for the histopathological provisions on tumor tissue. - Inclusion of patients can only up to the beginning of chemotherapy - If no chemotherapy must be given, inclusion within 6 months is possible after surgery
Exclusion criteria
Exclusion criteria: no
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| > Prospective recognition of the primary cases of breast cancer in men with the determination of recurrence-free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| > Determination of overall survival > Stage and biological characteristics of breast cancer > Validation of therapeutic modalities (medications, CHT, Op-type radiation) > Sensitivity of diagnosis (clinical examination, ultrasound, mammography) > Determining histopathological factors on tumor tissue | — |
Countries
Germany
Contacts
Public ContactSabrina Rudolph
Universitätsfrauenklinik
Outcome results
None listed